scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780170205 |
P698 | PubMed publication ID | 4131150 |
P2093 | author name string | Epstein WV | |
Grausz H | |||
P2860 | cites work | Cyclophosphamide in lupus nephritis: a controlled trial | Q34201904 |
The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
P433 | issue | 2 | |
P921 | main subject | proliferative glomerulonephritis | Q18556474 |
systemic lupus erythematosus | Q1485 | ||
glomerulonephritis | Q605006 | ||
P304 | page(s) | 129-142 | |
P577 | publication date | 1974-03-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus | |
P478 | volume | 17 |
Q69225849 | Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin |
Q40497391 | Clinical use of immunosuppressive drugs: part I |
Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
Q44009488 | Glomerulonephritis — 1974 |
Q33452842 | Immunologic findings, thrombocytopenia and disease activity in lupus nephritis |
Q36269226 | Immunosuppressive Therapy in Rheumatic Disease |
Q40665188 | Lupus nephritis in childhood and adolescence |
Q68125366 | Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) |
Q42823544 | Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study |
Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
Q80689056 | Outcome of lupus nephritis in Iranian children: prognostic significance of certain features |
Q52103115 | Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis |
Q34302895 | Problems with immunosuppressive agents in renal disease |
Q41331115 | Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis |
Q33824546 | Recent advances in the immunopathogenesis of systemic lupus erythematosus |
Q33987313 | Recent observations on central nervous system lupus erythematosus |
Q67564579 | The clinical aspects of systemic lupus erythematosus |
Q38791636 | The treatment of lupus nephritis |
Q67592070 | The treatment of the nephritis of lupus erythematosus |
Q64389051 | Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritis |
Search more.